China is launching its first AI-assisted personalised tumour vaccine production line in Beijing, offering new hope for millions battling the nation's second-leading cause of death.
The facility will be located in the Beijing Economic and Technological Development Zone
Jun 29, 2026
01:03 pm
What's the storyChina is gearing up to launch its first-ever production line for artificial intelligence (AI)-powered personalized tumor vaccines.
The facility is being developed by Beijing-based Likang Life Sciences and will be located in the Beijing Economic and Technological Development Zone.
Likang Life Sciences says it has developed a personalised vaccine using advanced tech to identify tumour-specific mutations.
Construction has begun in Beijing on China's first AI-powered personalized cancer vaccine production line, aiming to design…
Likang Life Sciences founder Chen Li explains how his Beijing startup is developing personalized mRNA cancer vaccines and why…
Researchers at the University of Cambridge have developed the first-ever vaccine component designed entirely by artificial…
It could help prevent future pandemics.
Oxford researchers, supported by the Medical Research Council, are developing personalized cancer vaccines using AI, leveraging…
